Background: Plasma platelet-activating factor-acetylhydrolase (PAF-AH) is known to catalyze platelet-activating factor (PAF). The single nucleotide polymorphism (SNP) of plasma PAF-AH gene (G994 -->T in exon 9) is associated with a decreased level of plasma PAF-AH activity. This study analyzed the risk of the SNP on graft occlusion of femoropopliteal bypass in patients with atherosclerotic occlusive disease.
Methods: We retrospectively assessed the patency of 50 above-knee femoropopliteal bypass grafting in 50 patients. Genomic DNA was analyzed for the mutant allele. Plasma PAF-AH activity was measured by radioimmunoassay.
Results: The 10-year cumulative primary patency of the bypass was 78.5% in GG (normal genotype) and 50.0% in GT (heterozygous) or TT (homozygous deficient) (P <.05, Kaplan-Meier method). The relative risk of graft failure in GT or TT genotypes was 1.68 (P =.08, Cox proportional hazards model). PAF-AH activity (nmol/min/50 microL) was 1.92 +/- 0.82 in patients with patent grafts and 1.42 +/- 0.47 in those with occluded grafts (mean +/- standard deviation; P <.05, unpaired t test).
Conclusions: The SNP of plasma PAF-AH was associated with a decreased primary graft patency of above-knee femoropopliteal bypass. The risk of graft failure may increase when patients have the SNP. To confirm the independent risk of graft failure by the SNP, further study is necessary and prospective study should be performed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1067/msy.2002.124931 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug-Coated Balloons in Autologous Vein Peripheral-Distal Bypass Graft Maintenance: Advancements and Potential Impact.
J Endovasc Ther
December 2024
Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina, Azienda Ospedaliera Universitaria Policlinico "G. Martino," Messina, Italy.
Introduction: Initial surgical revascularization has a recognized primary role in patients with critical limb-threatening ischemia with a high-quality great saphenous vein for conduit. However, approximately one-third of lower extremity vein grafts develop lesions threatening graft patency. Traditional treatments have limitations, highlighting the need for innovative solutions.
View Article and Find Full Text PDFCollateral vessel size and number could predict severe dissection after balloon angioplasty in patients with femoropopliteal artery chronic total occlusion.
Vascular
November 2024
Abant Izzet Baysal University, Faculty of Medicine, Department of Cardiology, Bolu, Turkey.
Article Synopsis
- - The study investigates how collateral vessels, which develop from arterioles due to arterial issues, may provide a natural bypass to improve walking performance in patients with peripheral arterial disease after treatments like balloon angioplasty.
- - It analyzed medical data from 824 patients undergoing endovascular treatments for femoropopliteal chronic total occlusion, ultimately focusing on 410 limbs and looking at the relationship between collateral vessels and vessel dissection severity.
- - Results indicate that severe dissections were more common with specific lesion types, longer occlusions, and certain characteristics of collateral vessels, suggesting that these factors could help predict complications following treatment.
Endovascular therapy via a femoro-femoral crossover bypass graft for chronic total occlusion of the superficial femoral artery: Two case reports.
SAGE Open Med Case Rep
November 2024
Department of Cardiovascular Medicine, Asahi General Hospital, Asahi, Chiba, Japan.
In patients with a femoropopliteal chronic total occlusion (CTO) after femoro-femoral (FF) bypass surgery, it is often difficult to perform endovascular therapy because of access site problems. We have treated two patients with CTO of the superficial femoral artery (SFA) using an FF crossover bypass graft. The two cases were a man with intermittent claudication and acute limb ischemia, respectively.
View Article and Find Full Text PDFTotal Contact Casting Remains an Effective Modality for Treatment of Diabetic Foot Ulcers.
Vasc Endovascular Surg
November 2024
Hyperbaric and Advanced Wound Healing Center, NYU Grossman School of Medicine, New York, NY, USA.
Article Synopsis
- * The study found that patients without healing had significantly higher rates of amputation and noncompliance compared to those whose ulcers healed, highlighting the importance of TCC adherence in treatment success.
- * Subgroup analysis revealed that patients undergoing revascularization interventions had better healing outcomes (66.7% healed) and noted lower ABI scores, indicating more severe vascular issues, compared to those who did not require additional procedures. *
Phage-Antibiotic Combination Therapy against Recurrent Septicaemia in a Patient with an Arterial Stent.
Antibiotics (Basel)
September 2024
Human Microbiome Research Program, Research Programs Unit and Medicum, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Intravascular stent infections are often associated with high risks of morbidity and mortality. We report here a case of a patient with an arterial stent and recurrent septicaemias successfully treated with phage-meropenem combination therapy. A 75-year-old female with arteriosclerosis and comorbidities went through a femoropopliteal bypass with prosthesis in the right inguinal area.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!